- Patent Title: Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome
-
Application No.: US14479084Application Date: 2014-09-05
-
Publication No.: US10261091B2Publication Date: 2019-04-16
- Inventor: Debraj GuhaThakurta , James Trager , Nadeem Sheikh
- Applicant: Dendreon Corporation
- Applicant Address: US WA Seattle
- Assignee: Dendreon Corporation
- Current Assignee: Dendreon Corporation
- Current Assignee Address: US WA Seattle
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/68 ; A61K39/00 ; G01N33/564 ; G16H50/50 ; G16H50/70
Abstract:
Compositions and methods are provided herein for predicting therapeutic outcome by measuring patient response to cellular antigen specific active immunotherapy (CASAI) using predetermined biomarkers.
Public/Granted literature
Information query
IPC分类:
